Related references
Note: Only part of the references are listed.FDA approves first drug to delay type 1 diabetes
Thiago Carvalho
NATURE MEDICINE (2023)
Challenges with Cell-based Therapies for Type 1 Diabetes Mellitus
Prakriti Siwakoti et al.
STEM CELL REVIEWS AND REPORTS (2023)
Adult-onset type 1 diabetes: A changing perspective
J. Burahmah et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2022)
Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial
Mahmoud Izadi et al.
STEM CELL RESEARCH & THERAPY (2022)
Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE
Diane L. Kamen et al.
LUPUS SCIENCE & MEDICINE (2022)
Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study br
Gabriel A. Gregory et al.
LANCET DIABETES & ENDOCRINOLOGY (2022)
Residual beta cell function in long-term type 1 diabetes associates with reduced incidence of hypoglycemia
Rose A. Gubitosi-Klug et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
One repeated transplantation of allogeneic umbilical cord mesenchymal stromal cells in type 1 diabetes: an open parallel controlled clinical study
Jing Lu et al.
STEM CELL RESEARCH & THERAPY (2021)
Adipose tissue-derived stromal/stem cells plus cholecalciferol: a pilot study in recent-onset type 1 diabetes patients
Joana Rodrigues Dantas et al.
ARCHIVES OF ENDOCRINOLOGY METABOLISM (2021)
Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis
Panayiota Petrou et al.
BRAIN (2020)
Umbilical cord as a long-term source of activatable mesenchymal stromal cells for immunomodulation
Anton Selich et al.
STEM CELL RESEARCH & THERAPY (2019)
Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities
Jacques Galipeau et al.
CELL STEM CELL (2018)
MSCs-cells with many sides
Katarina Le Blanc et al.
CYTOTHERAPY (2018)
Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells
Samantha F. H. de Witte et al.
STEM CELLS (2018)
Incidence of type 1 diabetes in China, 2010-13: population based study
Jianping Weng et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Incidence of type 1 diabetes in China, 2010-13: population based study
Jianping Weng et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank
Nicholas J. Thomas et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study
Araz Rawshani et al.
LANCET (2018)
Concise Review: Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells
John E. Davies et al.
STEM CELLS TRANSLATIONAL MEDICINE (2017)
Umbilical Cord Mesenchymal Stromal Cell With Autologous Bone Marrow Cell Transplantation in Established Type 1 Diabetes: A Pilot Randomized Controlled Open-Label Clinical Study to Assess Safety and Impact on Insulin Secretion
Jinquan Cai et al.
DIABETES CARE (2016)
Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose
Wei Hao et al.
DIABETES CARE (2016)
The clinical potential of low-level C-peptide secretion
Johnny Ludvigsson
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)
Mechanisms of mesenchymal stem/stromal cell function
Jeffrey L. Spees et al.
STEM CELL RESEARCH & THERAPY (2016)
Type 1 Diabetes Mellitus Donor Mesenchymal. Stromal Cells Exhibit Comparable Potency to Healthy Controls In Vitro
Lindsay C. Davies et al.
STEM CELLS TRANSLATIONAL MEDICINE (2016)
Global epidemiology of type 1 diabetes in young adults and adults: a systematic review
Paula A. Diaz-Valencia et al.
BMC PUBLIC HEALTH (2015)
Mesenchymal Stromal Cells to Halt the Progression of Type 1 Diabetes?
Per-Ola Carlsson et al.
CURRENT DIABETES REPORTS (2015)
Mesenchymal stem cells of different origin: Comparative evaluation of proliferative capacity, telomere length and pluripotency marker expression
Drenka Trivanovic et al.
LIFE SCIENCES (2015)
Preserved β-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells
Per-Ola Carlsson et al.
DIABETES (2015)
Chromosomal aberrations and deoxyribonucleic acid single-strand breaks in adipose-derived stem cells during long-term expansion in vitro
Katrin Froelich et al.
CYTOTHERAPY (2013)
TSG-6 Produced by hMSCs Delays the Onset of Autoimmune Diabetes by Suppressing Th1 Development and Enhancing Tolerogenicity
Daniel J. Kota et al.
DIABETES (2013)
Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6
Sara M. Melief et al.
HAEMATOLOGICA (2013)
Alterations in the Cellular Immune Compartment of Patients Treated with Third-Party Mesenchymal Stromal Cells Following Allogeneic Hematopoietic Stem Cell Transplantation
Regina Jitschin et al.
STEM CELLS (2013)
Multipotent Stromal Cells Induce Human Regulatory T Cells Through a Novel Pathway Involving Skewing of Monocytes Toward Anti-inflammatory Macrophages
Sara M. Melief et al.
STEM CELLS (2013)
Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy
Lena von Bahr et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Long term effects of the implantation of Wharton^|^rsquo;s jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus
Jianxia Hu et al.
ENDOCRINE JOURNAL (2012)
Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?
Guido Moll et al.
STEM CELLS (2012)
Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation
L. von Bahr et al.
STEM CELLS (2012)
Immunogenicity and Immunomodulatory Properties of Umbilical Cord Lining Mesenchymal Stem Cells
Tobias Deuse et al.
CELL TRANSPLANTATION (2011)
Congenic Mesenchymal Stem Cell Therapy Reverses Hyperglycemia in Experimental Type 1 Diabetes
Mollie Jurewicz et al.
DIABETES (2010)
Challenges in developing endpoints for type 1 diabetes intervention studies
Simona Cernea et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2009)
Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden
M. Thunander et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
High passage number of stem cells adversely affects stem cell activation and myocardial protection
Paul R. Crisostomo et al.
SHOCK (2006)
Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice
Ryang Hwa Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
β-cell function and the development of diabetes-related complications in the diabetes control and complications trial
MW Steffes et al.
DIABETES CARE (2003)
Share Paper
